首页> 外文期刊>Pharmaceutical Methods >Development and validation of UV-visible spectrophotometric baseline manipulation methodology for simultaneous analysis of drotraverine and etoricoxib in pharmaceutical dosage forms
【24h】

Development and validation of UV-visible spectrophotometric baseline manipulation methodology for simultaneous analysis of drotraverine and etoricoxib in pharmaceutical dosage forms

机译:紫外-可见分光光度基线操作方法的开发和验证,用于同时分析药物剂型中的卓维林和依托昔布

获取原文
           

摘要

Introduction: A simple, economical, precise, and accurate new UV spectrophotometricbaseline manipulation methodology for simultaneous determination of drotaverine(DRT) and etoricoxib (ETR) in a combined tablet dosage form has been developed.Materials and Methods:....................................................................................................................spectroscopy where the amplitudes at 274 and 351 nm were selected to determine ETRand DRT, respectively, in combined formulation and methanol was used as solvent...........................................................................................................................................................................................................................Results: The results of analysis have been validated statistically........ .................. ................ .................. ........ .................. ........ ................................ ...... ........ ..................method which were carried out by following the ICH guidelines. Conclusion: It has beenconcluded that a new simple and accurate UV spectrophotometric baseline manipulationmethod was developed for simultaneous determination of drotaverine and ETR ina combined tablet dosage form has been developed.
机译:简介:已开发出一种简单,经济,准确和准确的新型UV分光光度法基线操作方法,用于同时测定组合片剂剂型中的屈曲维林(DRT)和依托昔布(ETR)。材料和方法:....... ................................................... ................................................... ............…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………… ................................................... ................................................... ................................................... ................................................... .....结果:分析结果已经过统计学验证。 .................................................... ............................................................................ ..... ..................方法 遵循ICH指南进行。结论:结论是开发了一种新的简单而准确的紫外分光光度法基线处理方法,用于同时测定Drotaverine和ETR的组合片剂剂型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号